NET INCOME (LOSS) PER SHARE - Anti-dilutive shares excluded from the computations of diluted net income (loss) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Mar. 31, 2024 |
Mar. 31, 2023 |
Mar. 31, 2022 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share | |||||||||||||||
| Net income (loss) attributable to common stockholders used in basic earnings per share | $ (7,424) | $ (879) | $ (8,303) | $ (8,190) | $ (41,286) | $ (18,368) | $ 38,355 | ||||||||
| Add back: Excluded (gain) loss on assumed exercise of liability-classified common stock warrants during the period | 0 | (7,323) | (59,753) | ||||||||||||
| Net loss attributable to common stockholders used in diluted earnings per share | $ (7,424) | $ (879) | $ (8,303) | $ (8,190) | $ (41,286) | $ (25,691) | $ (21,398) | ||||||||
| Weighted average shares - basic (in shares) | 95,806 | 95,010 | 93,673 | 92,752 | 91,550 | 83,641 | 94,345 | 87,617 | 94,834 | 89,335 | 95,087 | 90,348 | 58,871 | ||
| Assumed exercise of dilutive warrants (in shares) | 0 | 840 | 7,146 | ||||||||||||
| Weighted average shares - diluted (in shares) | 95,806 | 95,010 | 93,711 | 92,752 | 92,773 | 85,756 | 94,345 | 89,315 | 94,834 | 90,440 | 95,087 | 91,188 | 66,017 | ||
| Net income (loss) per share attributable to common stockholders - basic (in dollars per share) | $ (0.20) | $ (0.10) | $ (0.04) | $ (0.10) | $ (0.11) | $ 0 | $ (0.08) | $ (0.01) | $ (0.13) | $ (0.09) | $ (0.24) | $ (0.10) | $ (0.43) | $ (0.20) | $ 0.65 |
| Net income (loss) per share attributable to common stockholders - diluted (in dollars per share) | $ (0.10) | $ (0.04) | $ (0.10) | $ (0.11) | $ 0 | $ (0.10) | $ (0.07) | $ (0.13) | $ (0.18) | $ (0.24) | $ (0.18) | $ (0.43) | $ (0.28) | $ (0.32) | |
| Antidilutive shares excluded (in shares) | 12,500 | 4,257 | 2,057 | ||||||||||||
| Stock awards | |||||||||||||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share | |||||||||||||||
| Antidilutive shares excluded (in shares) | 336 | 543 | 1,996 | ||||||||||||
| Warrants | |||||||||||||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share | |||||||||||||||
| Antidilutive shares excluded (in shares) | 12,164 | 3,706 | 50 | ||||||||||||
| ESPP | |||||||||||||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share | |||||||||||||||
| Antidilutive shares excluded (in shares) | 0 | 8 | 11 | ||||||||||||
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|